Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / COM
-
Number of holders
-
5
-
Total 13F shares, excl. options
-
104,487
-
Shares change
-
+82,621
-
Total reported value, excl. options
-
$122,250
-
Value change
-
+$79,322
-
Number of buys
-
5
-
Number of sells
-
1
-
Price
-
$1.17
Institutional Holders of Allarity Therapeutics, Inc. - COM (ALLR) as of Q4 2024
As of 31 Dec 2024 Allarity Therapeutics, Inc. - COM (ALLR) had 6 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 104,487 shares of stock of the company.
Largest 6 holders included Stonepine Capital Management, LLC, GOLDMAN SACHS GROUP INC, CITIGROUP INC, Tower Research Capital LLC (TRC), BANK OF AMERICA CORP /DE/, and UBS Group AG.
This table shows 6 institutional shareholders of the security as of 31 Dec 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.